ESMO FAMILY SITES
![]() |
![]() |
![]() |
The European Multidisciplinary Cancer Congress, Stockholm 23 – 27 September 2011
We are pleased to report that The European Multidisciplinary Cancer Congress was a great success with the participation of almost 16,000 people from 116 countries!
If you have any questions about webcasts, certificates of attendance or poster certificates, abstracts, press releases, etc., please contact the European Cancer Organisation (ECCO)
An overview of the hottest news and views from this year’s biggest European cancer congress:
Video highlights (exclusively by ESMO)
- Interview with Alberto Sobrero: aflibercept in combination with Folfiri for the treatment of patients with previously treated metastatic colorectal cancer - a new agent, finally
- Interview with Fabrice André: an independent expert comment on the impact of the ph-III BOLERO-2 study and a perspective on clinical practice consequences for patients with hormone refractory advanced breast cancer
- Interview with Karim Fizazi: Radium-223 Chloride proved to be effective in the treatment of patients with symptomatic bone metastases in castration-resistant prostrate cancer
- Interview with Fortunato Ciardiello: VANTAGE 014 – urgent need to identify new drugs against advanced pleural mesothelioma to face peack of cases in 10 years
Photo Gallery
Take a glimpse at our photo gallery just to see if you appear. Also included are photos of the very first ESMO National Society Summit, as well as our ever-popular Members’ Lounge.
A very big thank you once again to all those who took the time to come and see us at the booth or in the lounge. We really look forward to seeing you in Vienna, for the 37th ESMO Congress!
For further information including plenary sessions, teaching lectures, educational symposia, workshops, proffered paper sessions and so much more, visit http://www.ecco-org.eu






BACK TO TOP
PRINT THIS PAGE